VIAN Therapeutics
Developer of an early-stage biotechnology company intended to reduce the progression of cancer. The company specializes in making peptide drugs with enhanced efficacy, safety, and convenience, also wo...
Valuation
$7M
Market implied
Share Price
N/A
Total Raised
$1.3M
Last Round
N/A